IBDEI0J1 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8564,2)
;;=^5002357
;;^UTILITY(U,$J,358.3,8565,0)
;;=C22.2^^39^401^90
;;^UTILITY(U,$J,358.3,8565,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8565,1,3,0)
;;=3^Hepatoblastoma
;;^UTILITY(U,$J,358.3,8565,1,4,0)
;;=4^C22.2
;;^UTILITY(U,$J,358.3,8565,2)
;;=^5000935
;;^UTILITY(U,$J,358.3,8566,0)
;;=D58.9^^39^401^92
;;^UTILITY(U,$J,358.3,8566,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8566,1,3,0)
;;=3^Hereditary Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,8566,1,4,0)
;;=4^D58.9
;;^UTILITY(U,$J,358.3,8566,2)
;;=^5002322
;;^UTILITY(U,$J,358.3,8567,0)
;;=C81.99^^39^401^93
;;^UTILITY(U,$J,358.3,8567,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8567,1,3,0)
;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,8567,1,4,0)
;;=4^C81.99
;;^UTILITY(U,$J,358.3,8567,2)
;;=^5001460
;;^UTILITY(U,$J,358.3,8568,0)
;;=C81.90^^39^401^94
;;^UTILITY(U,$J,358.3,8568,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8568,1,3,0)
;;=3^Hodgkin Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,8568,1,4,0)
;;=4^C81.90
;;^UTILITY(U,$J,358.3,8568,2)
;;=^5001451
;;^UTILITY(U,$J,358.3,8569,0)
;;=D89.2^^39^401^95
;;^UTILITY(U,$J,358.3,8569,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8569,1,3,0)
;;=3^Hypergammaglobulenemia,Unspec
;;^UTILITY(U,$J,358.3,8569,1,4,0)
;;=4^D89.2
;;^UTILITY(U,$J,358.3,8569,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,8570,0)
;;=D05.12^^39^401^98
;;^UTILITY(U,$J,358.3,8570,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8570,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Left Breast
;;^UTILITY(U,$J,358.3,8570,1,4,0)
;;=4^D05.12
;;^UTILITY(U,$J,358.3,8570,2)
;;=^5001931
;;^UTILITY(U,$J,358.3,8571,0)
;;=D05.11^^39^401^99
;;^UTILITY(U,$J,358.3,8571,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8571,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Right Breast
;;^UTILITY(U,$J,358.3,8571,1,4,0)
;;=4^D05.11
;;^UTILITY(U,$J,358.3,8571,2)
;;=^5001930
;;^UTILITY(U,$J,358.3,8572,0)
;;=D05.10^^39^401^100
;;^UTILITY(U,$J,358.3,8572,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8572,1,3,0)
;;=3^Intraductal Carcinoma in Situ,Unspec Breast
;;^UTILITY(U,$J,358.3,8572,1,4,0)
;;=4^D05.10
;;^UTILITY(U,$J,358.3,8572,2)
;;=^5001929
;;^UTILITY(U,$J,358.3,8573,0)
;;=D50.0^^39^401^101
;;^UTILITY(U,$J,358.3,8573,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8573,1,3,0)
;;=3^Iron Deficiency Anemia Secondary to Blood Loss
;;^UTILITY(U,$J,358.3,8573,1,4,0)
;;=4^D50.0
;;^UTILITY(U,$J,358.3,8573,2)
;;=^267971
;;^UTILITY(U,$J,358.3,8574,0)
;;=D50.9^^39^401^102
;;^UTILITY(U,$J,358.3,8574,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8574,1,3,0)
;;=3^Iron Deficiency Anemia,Unspec
;;^UTILITY(U,$J,358.3,8574,1,4,0)
;;=4^D50.9
;;^UTILITY(U,$J,358.3,8574,2)
;;=^5002283
;;^UTILITY(U,$J,358.3,8575,0)
;;=C46.9^^39^401^103
;;^UTILITY(U,$J,358.3,8575,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8575,1,3,0)
;;=3^Kaposi's Sarcoma,Unspec
;;^UTILITY(U,$J,358.3,8575,1,4,0)
;;=4^C46.9
;;^UTILITY(U,$J,358.3,8575,2)
;;=^5001108
;;^UTILITY(U,$J,358.3,8576,0)
;;=C22.0^^39^401^104
;;^UTILITY(U,$J,358.3,8576,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8576,1,3,0)
;;=3^Liver Cell Carcinoma
;;^UTILITY(U,$J,358.3,8576,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,8576,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,8577,0)
;;=D05.02^^39^401^105
;;^UTILITY(U,$J,358.3,8577,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0J1 3771 printed Sep 23, 2025@19:25:37 Page 2
IBDEI0J1 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8564,2)
+2 ;;=^5002357
+3 ;;^UTILITY(U,$J,358.3,8565,0)
+4 ;;=C22.2^^39^401^90
+5 ;;^UTILITY(U,$J,358.3,8565,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,8565,1,3,0)
+8 ;;=3^Hepatoblastoma
+9 ;;^UTILITY(U,$J,358.3,8565,1,4,0)
+10 ;;=4^C22.2
+11 ;;^UTILITY(U,$J,358.3,8565,2)
+12 ;;=^5000935
+13 ;;^UTILITY(U,$J,358.3,8566,0)
+14 ;;=D58.9^^39^401^92
+15 ;;^UTILITY(U,$J,358.3,8566,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,8566,1,3,0)
+18 ;;=3^Hereditary Hemolytic Anemia,Unspec
+19 ;;^UTILITY(U,$J,358.3,8566,1,4,0)
+20 ;;=4^D58.9
+21 ;;^UTILITY(U,$J,358.3,8566,2)
+22 ;;=^5002322
+23 ;;^UTILITY(U,$J,358.3,8567,0)
+24 ;;=C81.99^^39^401^93
+25 ;;^UTILITY(U,$J,358.3,8567,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,8567,1,3,0)
+28 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
+29 ;;^UTILITY(U,$J,358.3,8567,1,4,0)
+30 ;;=4^C81.99
+31 ;;^UTILITY(U,$J,358.3,8567,2)
+32 ;;=^5001460
+33 ;;^UTILITY(U,$J,358.3,8568,0)
+34 ;;=C81.90^^39^401^94
+35 ;;^UTILITY(U,$J,358.3,8568,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,8568,1,3,0)
+38 ;;=3^Hodgkin Lymphoma,Unspec Site
+39 ;;^UTILITY(U,$J,358.3,8568,1,4,0)
+40 ;;=4^C81.90
+41 ;;^UTILITY(U,$J,358.3,8568,2)
+42 ;;=^5001451
+43 ;;^UTILITY(U,$J,358.3,8569,0)
+44 ;;=D89.2^^39^401^95
+45 ;;^UTILITY(U,$J,358.3,8569,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,8569,1,3,0)
+48 ;;=3^Hypergammaglobulenemia,Unspec
+49 ;;^UTILITY(U,$J,358.3,8569,1,4,0)
+50 ;;=4^D89.2
+51 ;;^UTILITY(U,$J,358.3,8569,2)
+52 ;;=^5002455
+53 ;;^UTILITY(U,$J,358.3,8570,0)
+54 ;;=D05.12^^39^401^98
+55 ;;^UTILITY(U,$J,358.3,8570,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,8570,1,3,0)
+58 ;;=3^Intraductal Carcinoma in Situ,Left Breast
+59 ;;^UTILITY(U,$J,358.3,8570,1,4,0)
+60 ;;=4^D05.12
+61 ;;^UTILITY(U,$J,358.3,8570,2)
+62 ;;=^5001931
+63 ;;^UTILITY(U,$J,358.3,8571,0)
+64 ;;=D05.11^^39^401^99
+65 ;;^UTILITY(U,$J,358.3,8571,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,8571,1,3,0)
+68 ;;=3^Intraductal Carcinoma in Situ,Right Breast
+69 ;;^UTILITY(U,$J,358.3,8571,1,4,0)
+70 ;;=4^D05.11
+71 ;;^UTILITY(U,$J,358.3,8571,2)
+72 ;;=^5001930
+73 ;;^UTILITY(U,$J,358.3,8572,0)
+74 ;;=D05.10^^39^401^100
+75 ;;^UTILITY(U,$J,358.3,8572,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,8572,1,3,0)
+78 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
+79 ;;^UTILITY(U,$J,358.3,8572,1,4,0)
+80 ;;=4^D05.10
+81 ;;^UTILITY(U,$J,358.3,8572,2)
+82 ;;=^5001929
+83 ;;^UTILITY(U,$J,358.3,8573,0)
+84 ;;=D50.0^^39^401^101
+85 ;;^UTILITY(U,$J,358.3,8573,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,8573,1,3,0)
+88 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
+89 ;;^UTILITY(U,$J,358.3,8573,1,4,0)
+90 ;;=4^D50.0
+91 ;;^UTILITY(U,$J,358.3,8573,2)
+92 ;;=^267971
+93 ;;^UTILITY(U,$J,358.3,8574,0)
+94 ;;=D50.9^^39^401^102
+95 ;;^UTILITY(U,$J,358.3,8574,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,8574,1,3,0)
+98 ;;=3^Iron Deficiency Anemia,Unspec
+99 ;;^UTILITY(U,$J,358.3,8574,1,4,0)
+100 ;;=4^D50.9
+101 ;;^UTILITY(U,$J,358.3,8574,2)
+102 ;;=^5002283
+103 ;;^UTILITY(U,$J,358.3,8575,0)
+104 ;;=C46.9^^39^401^103
+105 ;;^UTILITY(U,$J,358.3,8575,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,8575,1,3,0)
+108 ;;=3^Kaposi's Sarcoma,Unspec
+109 ;;^UTILITY(U,$J,358.3,8575,1,4,0)
+110 ;;=4^C46.9
+111 ;;^UTILITY(U,$J,358.3,8575,2)
+112 ;;=^5001108
+113 ;;^UTILITY(U,$J,358.3,8576,0)
+114 ;;=C22.0^^39^401^104
+115 ;;^UTILITY(U,$J,358.3,8576,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,8576,1,3,0)
+118 ;;=3^Liver Cell Carcinoma
+119 ;;^UTILITY(U,$J,358.3,8576,1,4,0)
+120 ;;=4^C22.0
+121 ;;^UTILITY(U,$J,358.3,8576,2)
+122 ;;=^5000933
+123 ;;^UTILITY(U,$J,358.3,8577,0)
+124 ;;=D05.02^^39^401^105
+125 ;;^UTILITY(U,$J,358.3,8577,1,0)
+126 ;;=^358.31IA^4^2
